Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Armin AhmadiDivision of Nephrology, Department of Medicine, University of California, Davis, California.ORCID 0000-0002-7711-2356
Ana P ValenciaDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington.ORCID 0000-0002-2833-6492
Gwénaëlle BegueKinesiology Department, California State University, Sacramento, California.ORCID 0000-0002-0636-8303
Jennifer E NormanDivision of Cardiovascular Medicine, Department of Internal Medicine, University of California, Davis, California.ORCID 0000-0002-6903-6031
Sili FanDepartment of Biostatistics, School of Medicine, University of California, Davis, California.
Blythe P Durbin-JohnsonDepartment of Biostatistics, School of Medicine, University of California, Davis, California.
Bradley N JennerDepartment of Biostatistics, School of Medicine, University of California, Davis, California.ORCID 0000-0003-1639-7965
Matthew D CampbellDepartment of Radiology, University of Washington, Seattle, Washington.ORCID 0000-0002-6632-2606
Gustavo ReyesDepartment of Radiology, University of Washington, Seattle, Washington.ORCID 0000-0003-3928-2968
Pankaj KapahiThe Buck Institute for Research on Aging, Novato, California.
Jonathan HimmelfarbDepartment of Medicine, Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington.ORCID 0000-0002-3319-1224
Ian H de BoerDepartment of Medicine, Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington.ORCID 0000-0003-1571-7592
David J MarcinekDepartment of Radiology and Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.ORCID 0000-0001-5187-2149
Bryan R KestenbaumDepartment of Medicine, Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington.
Jorge L GamboaSchool of Medicine, Vanderbilt University, Nashville, Tennessee.ORCID 0000-0002-4204-7670
Baback RoshanravanDivision of Nephrology, Department of Medicine, University of California, Davis, California.ORCID 0000-0003-1320-0442
Funding
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · 1986 to 2025
$12.6M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · UNIVERSITY OF WASHINGTON · 1986 to 2025
$7.0M
NRSA Training CoreTL1DK139565 · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2025 to 2025
$1.3M
Role of Mitochondrial Dysfunction in the Response to Exercise in Patients with Advanced Kidney DiseaseR01DK125794 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
A Pilot Trial of Nicotinamide Riboside and Coenzyme Q10 on Inflammation and Oxidative Stress in CKD. · full record | Socratic